Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes

被引:92
作者
Malcovati, Luca [1 ]
机构
[1] Univ Pavia, Sch Med, S Matteo Univ Hosp, Dept Hematol, I-27100 Pavia, Italy
关键词
myelodysplastic syndrome; secondary iron overload; prognosis; transfusion dependency; serum ferritin;
D O I
10.1016/S0145-2126(07)70459-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transfusion dependency is an independent prognostic factor in myelodysplastic syndromes (MDS). The detrimental effect on survival is related to the severity of transfusion requirement and is more noticeable in low-risk patients. Elevated serum ferritin levels have a poor prognostic impact on the survival of transfusion-dependent patients with refractory anemias, and can adversely affect the outcome of patients with MDS receiving allogeneic stem-cell transplantation. Sequential measurements of serum ferritin are useful for measuring secondary iron overload in MDS patients. The implementation of non-invasive methods for assessing tissue iron and organ function should clarify the impact of iron-mediated organ damage on patients with MDS. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S2 / S6
页数:5
相关论文
共 20 条
[1]  
Alessandrino EP, 2002, HAEMATOLOGICA, V87, P1286
[2]   Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia [J].
Anderson, LJ ;
Wonke, B ;
Prescott, E ;
Holden, S ;
Walker, JM ;
Pennell, DJ .
LANCET, 2002, 360 (9332) :516-520
[3]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[4]   Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation [J].
Armand, Philippe ;
Kim, Haesook T. ;
Cutler, Corey S. ;
Ho, Vincent T. ;
Koreth, John ;
Alyea, Edwin P. ;
Soiffer, Robert J. ;
Antin, Joseph H. .
BLOOD, 2007, 109 (10) :4586-4588
[5]   Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes [J].
Bowen, D ;
Culligan, D ;
Jowitt, S ;
Kelsey, S ;
Mufti, G ;
Oscier, D ;
Parker, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) :187-200
[6]   Myelodysplastic syndromes - Coping with ineffective hematopoiesis [J].
Cazzola, M ;
Malcovati, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (06) :536-538
[7]   Myocardial iron loading by magnetic resonance imaging T2*in good prognostic myelodysplastic syndrome patients on long-term blood transfusions [J].
Chacko, Joseph ;
Pennell, Dudley J. ;
Tanner, Mark A. ;
Hamblin, Terry J. ;
Wonke, Beatrix ;
Levy, Terry ;
Thomas, Peter W. ;
Killick, Sally B. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (05) :587-593
[8]   A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes:: delayed transplantation for low-risk myelodysplasia is associated with improved outcome [J].
Cutler, CS ;
Lee, SJ ;
Greenberg, P ;
Deeg, HJ ;
Pérez, WS ;
Anasetti, C ;
Bolwell, BJ ;
Cairo, MS ;
Gale, RP ;
Klein, JP ;
Lazarus, HM ;
Liesveld, JL ;
McCarthy, PL ;
Milone, GA ;
Rizzo, JD ;
Schultz, KR ;
Trigg, ME ;
Keating, A ;
Weisdorf, DJ ;
Antin, JH ;
Horowitz, MM .
BLOOD, 2004, 104 (02) :579-585
[9]   International scoring system for evaluating prognosis in myelodysplastic syndromes [J].
Greenberg, P ;
Cox, C ;
LeBeau, MM ;
Fenaux, P ;
Morel, P ;
Sanz, G ;
Sanz, M ;
Vallespi, T ;
Hamblin, T ;
Oscier, D ;
Ohyashiki, K ;
Toyama, K ;
Aul, C ;
Mufti, G ;
Bennett, J .
BLOOD, 1997, 89 (06) :2079-2088
[10]   NONSPECIFIC SERUM IRON IN THALASSEMIA - ABNORMAL SERUM IRON FRACTION OF POTENTIAL TOXICITY [J].
HERSHKO, C ;
GRAHAM, G ;
BATES, GW ;
RACHMILEWITZ, EA .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (02) :255-263